December 2021

Ahinsa Institute of Pharmacy located at Dondaicha on Nandurbar-Dhule National Highway and was established in 2016 under the aegis of Vardhaman Education and Welfare Society, Dondaicha. It is approved by AICTE, New Delhi, PCI, New Delhi, Govt. of Maharashtra, DTE Nashik & Affiliated to Dr. Babasaheb Ambedkar technological university Lonere, Raigad and MSBTE Mumbai.

CSMCRI with much scientific excitement has now achieved technological excellence with several granted patents in the core mandate of the institute and is one among the top performing national R&D laboratories in the country. At the beginning of 2011, the Institute has around 360 staff with 150 S&T staff on its roll and around 250 research fellows and project assistants pursing their doctoral programme.

Post : Project Associate - I

Ind-Swift Laboratories Ltd is the fastest growing API Group. We are having 6+ API Manufacturing Facilities across the globe. We are dealing in regulated market having approvals like USFDA, MHRA, TGA, ANVISA, PMDA, EU GMP.

Quality Control - Officer / Sr.Officer / Executive
Profile : - Knowledge of QMS -Handling FG Section
- Handling RM Section
Qualification :  B.Pharma / M.Pharma / M.Sc
Exp. : 3-5 years

Mitocon Biopharma is a global contract research organization serving the pharmaceutical, biopharmaceutical, medical device, and consumer healthcare industries. By offering high quality, value-add client specific solutions to meet current and future development needs.

Experienced Pharmacovigilance

Post : Drug Safety Associate-II / Assistant Manager / Managers For Medical Information Contact Center

Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE). MPE is the accumulation of fluid between the chest wall and lungs and is accompanied by malignant cells and/or tumors.

Antibiotic resistance is a race between us humans, who strive to find new antibiotics that can treat infectious diseases – and bacteria, which are becoming increasingly resistant. For now, bacteria are way ahead, which is why it is important for us to learn more about antibiotic resistance. A Danish research group has discovered a new piece of the puzzle that helps us better understand the 'enemy'.

Cipla Limited announced that it has received final approval for its Lanreotide Injection, from the United States Food and Drug Administration (US FDA). The FDA approval was based on a New Drug Application (NDA) submitted under the 505(b)(2) filing pathway. Lanreotide Injection is supplied in 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL singledose pre-filled syringes. It is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs).

Telix Pharmaceuticals Limited a global biopharmaceutical company focused on the development of diagnostic and therapeutic products based on molecularly targeted radiation announces that the United States Food and Drug Administration (FDA) has approved Telix’s lead prostate cancer imaging product, Illuccix®.

Central Medical Services Society (CMSS) has been established with the approval of Cabinet on 24.08.2011 as a Central Procurement Agency (CPA) to streamline drug procurement and distribution system of Department of Health & Family Welfare (DoHFW), Ministry of Health and Family Welfare, Government of India and to eliminate existing deficiencies.